Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
791 studies found for:    ( "January 30, 2012" : MAX ) [FIRST-RECEIVED-DATE] AND (lymphoma OR CLL [CONDITION ]) AND NOT myeloma [CONDITION] | Open Studies | Exclude Unknown
Found 791 studies with search of:   ( "January 30, 2012" : MAX ) [FIRST-RECEIVED-DATE] AND (lymphoma OR CLL [CONDITION ]) AND NOT myeloma [CONDITION] | Open Studies | Exclude Unknown
Recognized Terms and Synonyms:
lymphoma:   4720 studies
lymphomatous:   16 studies
chronic lymphocytic leukemia:   1024 studies
lymphocytic lymphoma:   706 studies
cll:   291 studies
b-cell leukemia:   11 studies
chronic lymphatic leukemia:   3 studies
chronic lymphoid leukemia:   5 studies
small cell lymphoma:   1 studies
chronic b-lymphocytic leukemia:   1 studies
chronic lymphoblastic leukemia:   1 studies
leukemia chronic lymphocytic:   1 studies
leukemia lymphocytic chronic:   3 studies
kahler disease:   4 studies
myeloma:   1776 studies
myelomatosis:   2 studies
plasma cell neoplasm:   342 studies
Related Terms:
Click on a related term to refine your search.
This will narrow your search by adding an additional search term.
If your search becomes too narrow (finds too few studies), broaden it by removing search terms with the Refine Search page.

B B-Cell
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
B-Cell Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoma, B-Cell
Bendamustine
Brentuximab
brentuximab vedotin
C CHOP
CLL
Chronic Lymphocytic Leukemia
D DLBCL
Diffuse Large B-Cell Lymphoma
H Hodgkin lymphoma
B-Cell Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
B-Cell Non-Hodgkin's Lymphoma
I Ibrutinib
Immunoproliferative Disorders
L Lenalidomide
Leukemia
Chronic Lymphocytic Leukemia
Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Lymphatic
Lymphatic Diseases
Lymphocytic
Chronic Lymphocytic Leukemia
Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
lymphocytic lymphoma
small lymphocytic lymphoma
Lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
B-Cell Non-Hodgkin's Lymphoma
cell lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
large cell lymphoma
mantle cell lymphoma
T-cell Lymphoma
follicular lymphoma
Hodgkin lymphoma
B-Cell Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
B-Cell Non-Hodgkin's Lymphoma
large cell lymphoma
lymphocytic lymphoma
small lymphocytic lymphoma
Lymphoma, B-Cell
Lymphoma, Non-Hodgkin
Lymphoma, T-Cell
mantle cell lymphoma
Non-Hodgkin's Lymphoma
B-Cell Non-Hodgkin's Lymphoma
small lymphocytic lymphoma
T-cell Lymphoma
Lymphoproliferative Disorders
N NHL
Neoplasms
Non-
B-Cell Non-Hodgkin's Lymphoma
Lymphoma, Non-Hodgkin
Non-Hodgkin's Lymphoma
B-Cell Non-Hodgkin's Lymphoma
R Refractory
Relapsed
Rituximab
T T-cell
Lymphoma, T-Cell
T-cell Lymphoma
B brentuximab vedotin
C cell
B-Cell
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
B-Cell Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoma, B-Cell
cell lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
large cell lymphoma
mantle cell lymphoma
T-cell Lymphoma
Lymphoma, B-Cell
Lymphoma, T-Cell
mantle cell lymphoma
T-cell
Lymphoma, T-Cell
T-cell Lymphoma
cycle
D diffuse
Diffuse Large B-Cell Lymphoma
F follicular
follicular lymphoma
L large
Diffuse Large B-Cell Lymphoma
large cell lymphoma
lymphocytic lymphoma
small lymphocytic lymphoma
M mantle cell lymphoma
marginal
marginal zone
R response rate
S small lymphocytic lymphoma
survival
V vedotin
brentuximab vedotin